Navigator Medicines, Inc., a clinical-stage biotech company leading the advancement of biologics for targeted immune regulation and restoration, today announced the appointments of Tausif (?Tosh') ...

GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the settlements, which will be funded through "existing resources," and said there ...

GSK's business development team have been working overtime of late, with three R&D deals announced in the last few days across Alzheimer's disease and cancer. The Alzheimer's agreement – with ...

Teva Pharmaceutical Industries Ltd. ADR-2.66% $19.77B ...

After hours: February 7 at 6:55:00 PM EST Loading Chart for GSK ...

New research shows that a network of subcellular structures similar to those responsible for propagating molecular signals that make muscles contract are also responsible for transmitting signals in ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.

After hours: 7 February at 18:55:00 GMT-5 ...

There were clear, person-centred pathways and protocols to help prevent risk to people’s continuity of care. The hospital discharge team told us their Home First and early-intervention approach ...

The UK funds that have ticked (just about) all the boxes since 2022 ...